Status:
COMPLETED
Study to Help Understand the Action of the Drug Etanercept for the Adult Patient With Psoriasis
Lead Sponsor:
Rockefeller University
Collaborating Sponsors:
Amgen
Conditions:
Psoriasis
Eligibility:
All Genders
18-70 years
Phase:
PHASE3
Brief Summary
The investigator's laboratory is studying a skin disease known as psoriasis. The purpose of this protocol is to study the action and the effects of Etanercept, on psoriasis. This medication has been s...
Detailed Description
The eligible patient will receive the drug Etanercept (Enbrel), and will self inject with Etanercept twice a week for the first 12 weeks. The patient will be taught to self inject the medication at ho...
Eligibility Criteria
Inclusion
- Gender: Male and Female
- Minimum Age: 18
- Maximum Age: 70
Exclusion
- Healthy Volunteers
Key Trial Info
Start Date :
October 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00116181
Start Date
October 1 2004
Last Update
March 18 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rockefeller University
New York, New York, United States, 10021